MIPLYFFA™ (arimoclomol)
| Full Name | MIPLYFFA™ (arimoclomol) |
| Drug | Miplyffa |
| Manufacturer | Zevra Therapeutics, Inc. |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | Use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adult and pediatric patients 2 years of age and older |
| Disease | Niemann-Pick disease type C (NPC) |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 888-668-4198 |
| Fax Number | 888-668-2143 |
| Product Website | miplyffa.com |